On Friday, Cassava Sciences Inc (SAVA) stock saw a decline, ending the day at $28.49 which represents a decrease of $-3.38 or -10.61% from the prior close of $31.87. The stock opened at $28.08 and ...

Casava stock falls as the company agrees to pay a cumulative fine exceeding $40 million to settle misleading claims charges ...

Bristol-Myers Squibb Company (BMY) shares rose 1.6% after the FDA approved its new drug for schizophrenia. Shares of Cassava Sciences (SAVA) plunged 10.6% after the company reached a $40 million ...

AT&T Inc (NYSE:T) announced Monday that it plans to sell its 70% ownership in satellite TV provider DirecTV to private equity firm TPG for $7.6 billion, marking the telecom giant's exit from a ...

Biotech company Cassava Sciences dropped over 10% following a settlement with the US SEC. The SEC had alleged that the ...

The Securities & Exchange Commission (SEC) has accused Cassava's founder and former chief executive Remi Barbier and former ...

The ASX could hit another record high on the last day of September despite a mixed bag on Wall Street. At 8am AEST, the SPI ...